Targeting the Notch signaling pathway in autoimmune diseases

Bibliography

• Invernizzi P. Future directions in genetic for autoimmune diseases. J Autoimmun 2009;33:1-2
   Google Scholar
• Leung PS, Dhirapong A, Wu PY, Tao MH. Gene therapy in autoimmune diseases: challenges and opportunities. Autoimmun Rev 2010;9(3):170-4
   Google Scholar
• Taylor SR, Salama AD, Joshi L, Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis. Arthritis Rheum 2009;60(5):1540-7
   PubMed Web of Science ®Google Scholar
• Youinou P, Jamin C. The weight of interleukin-6 in B cell-related autoimmune disorders. J Autoimmun 2009;32(3-40):206-10
   Google Scholar
• Guzman Moreno R. B-cell depletion in autoimmune diseases. Advances in autoimmunity. Autoimmun Rev 2009;8:585-90
   Google Scholar
• Fernandez D, Perl A. Metabolic control of T cell activation and death in SLE. Autoimmun Rev 2009;8(3):184-9
   Google Scholar
• Liu K, Mohan C. Altered B-cell signaling in lupus. Autoimmun Rev 2009;8(3):214-8
   Google Scholar
• Crispin JC, Tsokos GC. Transcriptional regulation of IL-2 in health and autoimmunity. Autoimmun Rev 2009;8(3):190-5
   Google Scholar
• Clauw DJ, Witter J. Pain and rheumatology: thinking outside the joint. Arthritis Rheum 2009;60(2):321-4
   PubMed Web of Science ®Google Scholar
• Alberto M. Marmont. Will hematopoietic stem cell transplantation cure human autoimmune diseases? J Autoimmun 2008;30:145-50
   Google Scholar
• Tomer Y, Huber A. The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun 2009;32(3-4):231-9
   Google Scholar
• Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999;284(5415):770-6
   PubMed Web of Science ®Google Scholar
• Tanigaki K, Honjo T. Regulation of lymphocyte development by notch signaling. Nat Immunol 2007;8(5):451-6
   Google Scholar
• de Celis JF, Barrio R, del Arco A, Genetic and molecular characterization of a notch mutation in its delta- and serrate-binding domain in Drosophila. Proc Natl Acad Sci USA 1993;90(9):4037-41
   Google Scholar
• Matsuno K, Diederich RJ, Go MJ, Deltex acts as a positive regulator of Notch signalling through interactions with the notch ankyrin repeats. Development 1995;121(8):2633-44
   Google Scholar
• Fryer CJ, Lamar E, Turbachova I, Mastermind mediates chromatin-specific transcription and turnover of the notch enhancer complex. Genes Dev 2002:16(11):1397-411
   Google Scholar
• Logeat F, Bessia C, Brou C, The notch1 receptor is cleaved constitutively by a furin-like convertase. Proc Natl Acad Sci USA 1998;95(14):8108-12
   Google Scholar
• Peschon JJ, Slack JL, Reddy P, An essential role for ectodomain shedding in mammalian development. Science 1998;282(5392):1281-4
   Google Scholar
• Iso T, Kedes L, Hamamori Y. HES and HERP families: multiple effectors of the notch signaling pathway. J Cell Physiol 2003;194(3):237-55
   Google Scholar
• Kojika S, Griffin JD. Notch receptors and hematopoiesis. Exp Hematol 2001;29(9):1041-52
   Google Scholar
• Wilson A, Radtke F. Multiple functions of notch signaling in self-renewing organs and cancer. FEBS Lett 2006;580(12):2860-8
   PubMed Web of Science ®Google Scholar
• Kumano K, Chiba S, Kunisato A, Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells. Immunity 2003;18(5):699-711
   PubMed Web of Science ®Google Scholar
• Robert-Moreno A, Espinosa L, de la Pompa JL, RBPjκ-dependent notch function regulates Gata2 and is essential for the formation of intra-embryonic hematopoietic cells. Development 2005;132(5):1117-26
   PubMed Web of Science ®Google Scholar
• Tsai FY, Keller G, Kuo FC, An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 1994;371(6494):221-6
   Google Scholar
• Suzuki T, Yokoyama Y, Kumano K, Highly efficient ex vivo expansion of human hematopoietic stem cells using delta1-Fc chimeric protein. Stem Cells 2006;24(11):2456-65
   Google Scholar
• Burns CE, Traver D, Mayhall E, Hematopoietic stem cell fate is established by the notch–runx pathway. Genes Dev 2005;19(19):2331-42
   PubMed Web of Science ®Google Scholar
• Kunisato A, Chiba S, Nakagami-Yamaguchi E, HES-1 preserves purified hematopoietic stem cells ex vivo and accumulatesvside population cells in vivo. Blood 2003;101(5):1777-83
   PubMed Web of Science ®Google Scholar
• Calvi LM, Adams GB, Weibrecht KW, Osteoblastic cells regulate the hematopoietic stem cell niche. Nature 2003;425(6960):841-6
   PubMed Web of Science ®Google Scholar
• Duncan AW, Rattis FM, Integration of notch and wnt signaling in hematopoietic stem cell maintenance. Nat Immunol 2005;6(3):314-22
   PubMed Web of Science ®Google Scholar
• Han H, Tanigaki K, Yamamoto N, Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision. Int Immunol 2002;14(6):637-45
   PubMed Web of Science ®Google Scholar
• Radtke F, Wilson A, Mancini SJ, Notch regulation of lymphocyte development and function. Nat Immunol 2004;5(3):247-53
   PubMed Web of Science ®Google Scholar
• Mancini SJ, Mantei N, Dumortier A, Jagged1-dependent notch signaling is dispensable for hematopoietic stem cell self-renewal and differentiation. Blood 2005;105(6):2340-42
   PubMed Web of Science ®Google Scholar
• Mercher T, Cornejo MG, Sears C, Notch signaling specifies megakaryocyte development from hematopoietic stem cells. Cell Stem Cell 2008;3(3):314-26
   PubMed Web of Science ®Google Scholar
• Schmitt TM, Zuniga-Pflucker JC. T-cell development, doing it in a dish. Immunol Rev 2006;209:95-102
   PubMed Web of Science ®Google Scholar
• Felli MP, Maroder M, Mitsiadis TA, Expression pattern of notch1, 2 and 3 and Jagged1 and 2 in lymphoid and stromal thymus components: distinct ligand-receptor interactions in intrathymic T cell development. Int Immunol 1999;11(7):1017-25
   Google Scholar
• Amsen D, Blander JM, Lee GR, Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 2004;117(4):515-26
   PubMed Web of Science ®Google Scholar
• Wilson A, MacDonald HR, Radtke F. Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus. J Exp Med 2001;194(7):1003-12
   PubMed Web of Science ®Google Scholar
• Asano N, Watanabe T, Kitani A, Notch1 signaling and regulatory T cell function. J Immunol 2008;180(5):2796-804
   PubMed Web of Science ®Google Scholar
• Ostroukhova M, Qi Z, Oriss TB, A. Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-beta. J Clin Invest 2006;116(4):996-1004
   Google Scholar
• Jurynczyk M, Jurewicz A, Raine CS, Notch3 inhibition in myelin-reactive T cells down-regulates protein kinase Cθ and attenuates experimental autoimmune encephalomyelitis. J Immunol 2008;180(4):2634-40
   PubMed Web of Science ®Google Scholar
• Saito T, Chiba S, Ichikawa M, Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity 2003;18(5):675-85
   PubMed Web of Science ®Google Scholar
• He F, Wang L, Hu XB, Notch and BCR signaling synergistically promote the proliferation of Raji B-lymphoma cells. Leuk Res 2009;33(6):798-802
   Google Scholar
• Santos MA, Sarmento LM, Rebelo M, Notch1 engagement by delta-like-1 promotes differentiation of B lymphocytes to antibody-secreting cells. PNAS 2007;104(39):15454-9
   PubMed Web of Science ®Google Scholar
• Weijzen S, Rizzo P, Braid M, Activation of notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med 2002;8(9):979-86
   Google Scholar
• Miele L. Notch signaling. Clin Cancer Res 2006;12(4):1074-9
   Google Scholar
• Shin HM, Minter LM, Cho OH, Notch1 augments NF-κB activity by facilitating its nuclear retention. EMBO J 2006;25(1):129-38
   PubMed Web of Science ®Google Scholar
• Pitsouli C, Delidakis C. The interplay between DSL proteins and ubiquitin ligases in notch signaling. Development 2005;132(18):4041-50
   Google Scholar
• Okajima T, Irvine KD. Regulation of notch signaling by O-linked fucose. Cell 2002;111(6):893-904
   Google Scholar
• Edwards DR, Handsley MM, Pennington CJ. The ADAM metalloproteinases. Mol Aspects Med 2008; 29(5):258-89
   PubMed Web of Science ®Google Scholar
• Gupta-Rossi N, Six E, LeBail O, Monoubiquitination and endocytosis direct gamma-secretase cleavage of activated notch receptor. J Cell Biol 2004;166(1):73-83
   Google Scholar
• Nam Y, Sliz P, Pear WS, Cooperative assembly of higher-order Notch complexes functions as a switch to induce transcription. Proc Natl Acad Sci USA 2007;104:2103-8
   PubMedGoogle Scholar
• Yamaguchi M, Tonou-Fujimori N, Komori A, Histone deacetylase 1 regulates retinal neurogenesis in zebrafish by suppressing wnt and notch signaling pathways. Development 2005;132(13):3027-43
   Google Scholar
• Wang Z, Li Y, Banerjee S, Emerging role of notch in stem cells and cancer. Cancer Lett 2009;279(1):8-12
   Google Scholar
• Leong KG, Karsan A. Recent insights into the role of notch signaling in tumorigenesis. Blood 2006;107(6):2223-33
   PubMed Web of Science ®Google Scholar
• Liu ZJ, Xiao M, Balint K, Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression. Cancer Res 2006;66(8):4182-90
   Google Scholar
• Rizzo P, Miao H, Miele L, Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res 2008;68(13):5226-35
   Google Scholar
• Engin F, Bertin T, Ma O, Notch signaling contributes to the pathogenesis of human osteosarcomas. Hum Mol Genet 2009;18(8):1464-70
   Google Scholar
• Suwanjunee S, Wongchana W, Palaga T. Inhibition of gamma-secretase affects proliferation of leukemia and hepatoma cell lines through notch signaling. Anticancer Drugs 2008;19(5):477-86
   Google Scholar
• Purow BW, Haque RM, Noel MW. Expression of notch-1 and its ligands, delta-like-1 and jagged-1, is critical for glioma cell survival and proliferation. Cancer Res 2005;65(6):2353-63
   PubMedGoogle Scholar
• Kang S, Yang C, Luo R. Induction of CCL2 by siMAML1 through upregulation of tweakR in melanoma cells. Biochem Biophys Res Commun 2008;372(4):629-33
   Google Scholar
• Hoey T, Yen WC, Axelrod F, DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency. Cell Stem Cell 2009;5(2):168-77
   Google Scholar
• Bellavia D, Campese AF, Checquolo S, Combined expression of pTalpha and notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis. Proc Natl Acad Sci USA 2002;99(6):3788-93
   Google Scholar
• Jundt F, Schwarzer R, Dörken B. Notch signaling in leukemias and lymphomas. Curr Mol Med 2008;8(1):51-9
   Google Scholar
• Weng A, Ferrando A, Lee W, Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004;306(5694):269-71
   PubMed Web of Science ®Google Scholar
• De Keersmaecker K, Lahortiga I, Mentens N, In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia. Haematologica 2008;93(4):533-42
   Google Scholar
• Moellering R, Cornejo M, Rocknik J, Direct inhibition of the notch transactivation complex with synthetic constrained peptides in T-cell acute lymphoblastic leukemia [abstract]. Blood 2007;110:2819
   Google Scholar
• Guo D, Ye J, Dai J, Notch1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines. Leuk Res 2009;33(5):678-85
   Google Scholar
• Guo D, Ye J, Li L, Down-regulation of notch-1 increases co-cultured Jurkat cell sensitivity to chemotherapy. Leuk Lymphoma 2009;50(2):270-8
   Google Scholar
• Palomero T, Dominguez M, Ferrando AA. The role of the PTEN/AKT pathway in notch1-induced leukemia. Cell Cycle 2008;7(8):965-70
   Google Scholar
• Jundt F, Probsting KS, Anagnostopoulos I, Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. Blood 2004;103(9):3511-5
   PubMed Web of Science ®Google Scholar
• Zweidler-McKay P, Rodriguez C, Karnell F, Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies. Blood 2005;106(12):3898-906
   Google Scholar
• Yin DD, Fan FY, Hu XB, Notch signaling inhibits the growth of the human chronic myeloid leukemia cell line K562. Leuk Res 2009;33(1):109-14
   Google Scholar
• Tohda S, Kogoshi H, Murakami N. Diverse effects of the notch ligands jagged1 and delta1 on the growth and differentiation of primary acute myeloblastic leukemia cells. Exp Hematol 2005;33(5):558-5
   Google Scholar
• Chen PM, Yen CC, Wang WS, Down-regulation of Notch-1 expression decreases PU.1-mediated myeloid differentiation signaling in acute myeloid leukemia. Int J Oncol 2008;32:1335-41
   PubMed Web of Science ®Google Scholar
• Park H, Li Z, Yang XO, A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005;6(11):1133-41
   Google Scholar
• Chang A, Tourtelotte WW, Rudick R, Trapp BD. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 2002;346(3):165-73
   PubMed Web of Science ®Google Scholar
• John GR, Shankar SL, Shafit-Zagardo B, Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med 2002;8(10):1115-21
   Google Scholar
• Genoud S, Lappe-Siefke C, Goebbels S, Notch1 control of oligodendrocyte differentiation in the spinal cord. J Cell Biol 2002;158(4):709-18
   Google Scholar
• Minter LM, Turley DM, Das P, Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing notch upregulation of Tbx21. Nat Immunol 2005;6:680-8
   PubMed Web of Science ®Google Scholar
• Jurynczyk M, Jurewicz A, Bielecki B, Overcoming failure to repair demyelination in EAE: gamma-secretase inhibition of notch signaling. J Neurol Sci 2008;265(1-2):5-11
   Google Scholar
• Stidworthy MF, Genoud S, Li WW, Notch1 and jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination. Brain 2004;127(9):1928-41
   Google Scholar
• Elyaman W, Bradshaw EM, Wang Y, JAGGED1 and delta1 differentially regulate the outcome of experimental autoimmune encephalomyelitis. J Immunol 2007;179(9):5990-8
   PubMed Web of Science ®Google Scholar
• Lit LC, Wong CK, Li EK, Elevated gene expression of Th/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus. J Rheumatol 2007;34(1):89-96
   Google Scholar
• Sodsai P, Hirankarn N, Avihingsanon Y, Defects in notch1 upregulation upon activation of T cells from patients with systemic lupus erythematosus are related to lupus disease activity. Lupus 2008;17(7):645-53
   Google Scholar
• Teachey DT, Seif AE, Brown VI, Targeting notch signaling in autoimmune and lymphoproliferative disease. Blood 2008;111(2):705-14
   Google Scholar
• Kishimoto H, Sprent J. A defect in central tolerance in NOD mice. Nat Immunol 2001;2(11):1025-31
   Google Scholar
• Jiao Z, Wang W, Jia R, Accumulation of FoxP3-expressing CD4+ CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis. Scand J Rheumatol 2007;36(6):428-33
   Google Scholar
• Nakazawa M, Ishii H, Nakamura H, NFkappaB2 (p52) promoter activation via Notch signaling pathway in rheumatoid synoviocytes. Int J Mol Med 2001;7(1):31-5
   Google Scholar
• Kijima M, Iwata A, Maekawa Y, Jagged1 suppresses collagen-induced arthritis by indirectly providing a negative signal in CD8+ T cells. J Immunol 2009;182(6):3566-72
   Google Scholar
• Zhi Jun Jiao, Wen Hong Wang, Shi He Shao. Modulating notch pathway using gamma-secretase inhibitors for the immunotherapy of rheumatoid arthritis. Biosci Hypotheses 2008;1(6): 332-3
   Google Scholar
• Zamurovic N, Cappellen D, Rohner D. Coordinated activation of notch, wnt, and transforming growth factor-beta signaling pathways in bone morphogenic protein 2-induced osteogenesis. Notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activity. J Biol Chem 2004;279(36):37704-15
   Google Scholar
• Cooke A, Phillips JM, Parish NM. Tolerogenic strategies to halt or prevent type 1 diabetes. Nat Immunol 2001;2(9):810-5
   Google Scholar
• Yoon JW, Jun HS. Cellular and molecular pathogenetic mechanisms of insulin dependent diabetes mellitus. Ann NY Acad Sci 2001;928:200-11
   PubMed Web of Science ®Google Scholar
• Anastasi E, Campese AF, Bellavia D, Expression of activated notch3 in transgenic mice enhances generation of T regulatory cells and protects against experimental autoimmune diabetes. J Immunol 2003;171(9):4504-11
   PubMed Web of Science ®Google Scholar
• Darville MI, Eizirik DL. Notch signaling: a mediator of beta-cell de-differentiation in diabetes? Biochem Biophys Res Commun 2006;339(4):1063-8
   Google Scholar
• Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134(2):577-94
   PubMed Web of Science ®Google Scholar
• Gersemann M, Becker S, Kübler I, Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis. Differentiation 2009;77(1):84-94
   Google Scholar
• Okamoto R, Tsuchiya K, Nemoto Y, Requirement of notch activation during regeneration of the intestinal epithelia. Am J Physiol Gastrointest Liver Physiol 2009;296(1):23-35
   Google Scholar
• Okamoto R, Watanabe M. Notch signalling in colonic epithelial cells: potential roles in inflammatory bowel disease and tissue repair. Mech Dev 2009;126(1):291-304
   Google Scholar
• Segal JB, Powe NR. Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Haemost 2006;4(11):2377-83
   Google Scholar
• Semple JW, Lazarus AH, Freedman J. The cellular immunology associated with autoimmune thrombocytopenic purpura: an update. Transfus Sci 1998;19(3):245-51
   Google Scholar
• Ma D, Zhu X, Zhao P, Profile of Th17 cytokines (IL-17, TGF-beta, IL-6) and Th1 cytokine (IFN-gamma) in patients with immune thrombocytopenic purpura. Ann Hematol 2008;87(11):899-904
   Google Scholar
• Yu J, Heck S, Patel V, Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura. Blood 2008;112(4):1325-8
   Google Scholar
• Cines DB, McMillan R. Management of adult idiopathic thrombocytopenic purpura. Annu Rev Med 2005;56:425-42
   PubMed Web of Science ®Google Scholar
• Bussel JB, Provan D, Shamsi T. Effect of eltrombopag on platelet counts and bleeding duringtreatment of chronic idiopathic thrombocytopenic purpura:a randomised, double-blind, placebo-controlled trial. Lancet 2009;373(9664):641-8
   Google Scholar
• Ma D, Dai J, Zhu X, Aberrant expression of notch signaling molecules in patients with immune thrombocytopenic purpura. Ann Hematol 2010;89(2):155-61
   Google Scholar
• Garber K. Notch emerges as new cancer drug target. J Natl Cancer Inst 2007;99(17):1284-5
   Google Scholar
• Siemers ER, Quinn JF, Kaye J, Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease. Neurology 2006;66(4):602-4
   PubMed Web of Science ®Google Scholar
• Kukar T, Golde TE. Possible mechanisms of action of NSAIDs and related compounds that modulate gamma-secretase cleavage. Curr Top Med Chem 2008;8(1):47-53
   Google Scholar
• Dai J, Ma D, Zang S, Cross-talk between Notch and EGFR signaling in human breast cancer cells. Cancer Invest 2009;27(5):533-40
   Google Scholar
• O'Neil J, Calvo J, McKenna K, Activating notch1 mutations in mouse models of T-ALL. Blood 2006;107(2):781-85
   Google Scholar
• Deangelo D, Stone R, Silverman L, A phase I clinical trial of the notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and other leukemias [abstract]. J Clin Oncol 2006;24:6585
   Web of Science ®Google Scholar
• Kogoshi H, Sato T, Koyama T, gamma-Secretase inhibitors suppress the growth of leukemia and lymphoma cells. Oncol Rep 2007;18(1):77-80
   Google Scholar
• Tohda S, Sato T, Kogoshi H, Establishment of a novel B-cell lymphoma cell line with suppressed growth by gamma-secretase inhibitors. Leuk Res 2006;30(11):1385-90
   Google Scholar
• Nefedova Y, Sullivan D, Bolick S, Inhibition of notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy. Blood 2008;111(4):2220-9
   Google Scholar
• Palomero T, Barnes K, Real P, CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors. Leukemia 2006;20(7):1279-87
   Google Scholar
• Palomero T, McKenna K, O-Neil J, Activating mutations in NOTCH1 in acute myeloid leukemia and lineage switch leukemias. Leukemia 2006;20(11):1963-6
   Google Scholar